Sumitomo Mitsui Trust Holdings, Inc. Biogen Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 391,496 shares of BIIB stock, worth $55.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
391,496
Previous 370,128
5.77%
Holding current value
$55.8 Million
Previous $71.7 Million
16.56%
% of portfolio
0.04%
Previous 0.05%
Shares
31 transactions
Others Institutions Holding BIIB
# of Institutions
993Shares Held
131MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.38 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.32 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.05 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$749 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...